US Patent

US7741374 — Methods of use of fenofibric acid

Method of Use · Assigned to Mutual Pharmaceutical Co Inc · Expires 2027-08-20 · 1y remaining

Vulnerability score 80/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of using fenofibric acid formulations, specifically those containing 105 mg of fenofibric acid.

USPTO Abstract

Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms.

Drugs covered by this patent

fenofibric-acid (FENOFIBRIC ACID)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1061`	—	fenofibric-acid
`U-1061`	—	fenofibric-acid

Patent Metadata

Patent number: US7741374
Jurisdiction: US
Classification: Method of Use
Expires: 2027-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Mutual Pharmaceutical Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.